Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jenn Marte"'
Autor:
Jeffrey Schlom, Ravi Madan, Seth Steinberg, James Gulley, Caroline Jochems, Renee Donahue, Sheri McMahon, Lisa Cordes, Julius Strauss, Fatima Karzai, Jason Redman, Charalampos Floudas, Clint Allen, Douglas Brough, Amy Lankford, Jenn Marte
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/8a5d294ad1844c6792d8983bd9216c7c
Autor:
Joshua A, Welsh, Bryce, Killingsworth, Julia, Kepley, Tim, Traynor, Sean, Cook, Jason, Savage, Jenn, Marte, Min-Jung, Lee, Hoyoung M, Maeng, Michelle L, Pleet, Setty, Magana, André, Gorgens, Cecile L, Maire, Katrin, Lamszus, Franz L, Ricklefs, Maria J, Merino, W Marston, Linehan, Tim, Greten, Tomer, Cooks, Curtis C, Harris, Andrea, Apolo, Asim, Abdel-Mageed, Alexander R, Ivanov, Jane B, Trepel, Matthew, Roth, Mercedes, Tkach, Aleksandar, Milosavljevic, Clotilde, Théry, Amy, LeBlanc, Jay A, Berzofsky, Eytan, Ruppin, Kenneth, Aldape, Kevin, Camphausen, James L, Gulley, Ionita, Ghiran, Steve, Jacobson, Jennifer C, Jones
Publikováno v:
Cell reports methods. 2(1)
Extracellular vesicles (EVs) of various types are released or shed from all cells. EVs carry proteins and contain additional protein and nucleic acid cargo that relates to their biogenesis and cell of origin. EV cargo in liquid biopsies is of widespr
Autor:
Franz Ricklefs, Steven Jacobson, Matthew E. Roth, Katrin Lamszus, Tim F. Greten, Tomer Cooks, Jay A. Berzofsky, W. Marston Linehan, Asim B. Abdel-Mageed, Curtis C. Harris, Tim Traynor, Michelle Pleet, Cecile L. Maire, Sean Cook, Clotilde Théry, André Görgens, Hoyoung Maeng, Joshua A. Welsh, Min-Jung Lee, Jane B. Trepel, Kenneth Aldape, Maria J. Merino, Julia Kepley, Jennifer Jones, Aleksandar Milosavljevic, Jenn Marte, Alexander R. Ivanov, Bryce Killingsworth, Setty Magana, Eytan Ruppin, Amy K. LeBlanc, Kevin Camphausen, Ionita Ghiran, Mercedes Tkach, Jason E. Savage, James L. Gulley, Andrea B. Apolo
Publikováno v:
SSRN Electronic Journal.
Extracellular vesicles (EVs) of various types are released or shed from all cells. EVs carry proteins and contain additional protein and nucleic acid cargo that relates to their biogenesis and cell of origin. EV cargo in liquid biopsies of widespread
Autor:
Joshua A. Welsh, Bryce Killingsworth, Julia Kepley, Tim Traynor, Sean Cook, Jason Savage, Jenn Marte, Min-Jung Lee, Hoyoung M. Maeng, Michelle L. Pleet, Setty Magana, André Gorgens, Cecile L. Maire, Katrin Lamszus, Franz L. Ricklefs, Maria J. Merino, W. Marston Linehan, Tim Greten, Tomer Cooks, Curtis C. Harris, Andrea Apolo, Asim Abdel-Mageed, Alexander R. Ivanov, Jane B. Trepel, Matthew Roth, Mercedes Tkach, Aleksandar Milosavljevic, Clotilde Théry, Amy LeBlanc, Jay A. Berzofsky, Eytan Ruppin, Kenneth Aldape, Kevin Camphausen, James L. Gulley, Ionita Ghiran, Steve Jacobson, Jennifer C. Jones
Publikováno v:
Cell Reports Methods. 2:100136
Autor:
Sheri McMahon, Ravi A. Madan, James L. Gulley, Charalampos S. Floudas, Jason M. Redman, Jenn Marte, Clint T. Allen, Julius Strauss, Caroline Jochems, Amy Lankford, Seth M. Steinberg, Lisa M. Cordes, Douglas E. Brough, Fatima Karzai, Renee N. Donahue, Jeffrey Schlom
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPRGN-2009 is a novel gorilla adenovirus vaccine containing 35 non-HLA-restricted epitopes of HPV 16 and 18 which is being tested in an open-label, NCI-sponsored, single-center Phase I/II study alone and combined with the bifunctional TGF-β
Autor:
Clint T. Allen, Ravi A. Madan, Houssein Abdul Sater, Lisa M. Cordes, Julius Strauss, Jeffrey Schlom, Jason M. Redman, Charalampos S. Floudas, Douglas E. Brough, Fatima Karzai, Nyall R. London, James L. Gulley, Renee N. Donahue, Sheri McMahon, Seth M. Steinberg, Jenn Marte, Caroline Jochems, Amy Lankford, Marijo Bilusic
Publikováno v:
Journal of Clinical Oncology. 39:TPS6092-TPS6092
TPS6092 Background: R/M HPVC (cervical, anal, oropharyngeal, etc.) are incurable by current therapies. For newly diagnosed LA HPV-OPSCC standard-of-care (SOC) is radiotherapy ± chemotherapy (C/RT) or surgery ± adjuvant C/RT, with considerable risk
Autor:
James L. Gulley, Charalampos S. Floudas, Lisa M. Cordes, Fatima Karzai, Jeffrey Schlom, Elizabeth Lamping, Julius Strauss, Jason M. Redman, Ravi A. Madan, Deneise C Francis, Michell Manu, Caroline Jochems, Renee N. Donahue, Scott M. Norberg, Marijo Bilusic, Jenn Marte, Frank K. Bedu-Addo, Christian S. Hinrichs, Houssein Abdul Sater, Lauren Virginia Wood
Publikováno v:
Journal of Clinical Oncology. 39:2501-2501
2501 Background: There are more than 630,000 cases of HPV associated malignancies including cervical, oropharyngeal and anal cancer worldwide annually. HPV 16 is responsible for the majority of these cases. About 15-20% of HPV associated malignancies
Autor:
Marijo Bilusic, Renee N. Donahue, Jenn Marte, Peter Joseph DeMaria, Seth M. Steinberg, Mark R. Gilbert, Ravi A. Madan, Julius Strauss, James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Deric M. Park
Publikováno v:
Journal of Clinical Oncology. 38:11527-11527
11527 Background: Chordoma is a rare neoplasm of the notochord that overexpresses brachyury, a transcription factor associated with epithelial-to-mesenchymal transition, metastasis, poor prognosis, and chemotherapy resistance. GI-6301 is a recombinan
Autor:
George Zaki, Beatriz Walter Rodriguez, Houssein Abdul Sater, Jenn Marte, Jeffrey D. Robinson, Margaret E. Gatti-Mays, Fatima Karzai, Charalampos S. Floudas, James L. Gulley, Ravi A. Madan, Jason M. Redman, Marijo Bilusic, Julius Strauss, Arun Rajan, Andrew Wiseman, Jeffrey Schlom, Lisa M. Cordes
Publikováno v:
Journal of Clinical Oncology. 38:3070-3070
3070 Background: Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII receptor (TGF-β “trap”) fused to a human IgG1 mAb blocking PD-L1. In preclinical models, bintrafusp alfa treatment
Autor:
Marijo Bilusic, Guinevere Chun, Helen Owens, Daniel P. Petrylak, Philip M. Arlen, Amy Hankin, Joseph Kim, Fatima Karzai, William D. Figg, Ravi A. Madan, Lisa M. Cordes, Munjid Al Harthy, James L. Gulley, Marc R. Theoret, Anna Couvillon, William L. Dahut, Jenn Marte
Publikováno v:
Journal of Clinical Oncology. 37:173-173
173 Background: A phase I study of Cabozantinib (C) in combination with docetaxel (D) and prednisone (P) in patients (pts) with mCRPC determined that 40 mg daily was the maximum tolerated dose of C in combination with D and P (C+DP). We report a pool